Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Limbic system dysfunction as a factor in some schizophreniform psychoses: case report and overview.

D J MacCrimmon, G B Jones

    Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    New approaches to pyrrolo[2,1-c][1,4]benzodiazepines: synthesis, DNA-binding and cytotoxicity of DC-81.

    Tetrahedron·2018
    Same author

    Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers.

    Pharmaceutical research·2017
    Same author

    CASUALTY CARE in the Classroom. Inside the MercyRockford Health System's hemorrhage control program for schools.

    EMS world·2016
    Same author

    Towards next generation adenosine A(2A) receptor antagonists.

    Current medicinal chemistry·2014
    Same author

    Surgical diagnosis of acute injuries of the knee joint.

    The Surgical clinics of North America·2010
    Same author

    Parturition with Fractured Femur.

    British medical journal·2010

    Carbamazepine effectively treated schizophreniform psychosis unresponsive to neuroleptics, suggesting Limbic System dysfunction may be a key factor in treatment-resistant cases.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Schizophreniform psychosis often presents challenges in treatment.
    • Neuroleptic medications are standard but not universally effective.
    • The Limbic System is implicated in various psychiatric disorders.

    Observation:

    • A young woman presented with schizophreniform psychosis.
    • Her condition was resistant to conventional neuroleptic treatment.
    • A novel therapeutic approach was explored.

    Findings:

    • Carbamazepine demonstrated significant efficacy in managing the patient's psychosis.
    • This response suggests a potential role for Carbamazepine in treatment-resistant cases.
    • Evidence points towards underlying Limbic System dysfunction.

    Related Experiment Videos

    Implications:

    • Carbamazepine may be a viable alternative for specific treatment-resistant schizophreniform psychosis.
    • Further research into Limbic System dysfunction in psychosis is warranted.
    • This case highlights the need for personalized treatment strategies in psychiatry.